Tricuspid and Bicuspid Valves Present More Coincidences Than Expected

There is more and more positive evidence that new-generation transcatheter valves, originally designed to treat tricuspid aortic valves, work perfectly fine on bicuspid aortic valves.

Más coincidencias de las esperadas entre válvulas bicúspides y tricúspides

A comparison of computerized tomography (CT) scans obtained before and after the procedure showed that the most commonly used devices appear to reshape the aortic annulus to the same degree in both standard patients and in patients with bicuspid valves.


Read also: Transcatheter Reduction or Surgery for Paravalvular Leak Repair?”


The BAVARD multicenter register, presented at PCR London Valves 2017, only looked at imaging results, but all patients included are being tracked in order to obtain information on endpoints such as paravalvular leak, stroke, bleeding, pacemaker implantations, etc.

 

In the current analysis, investigators reviewed pre- and post-implantation CT scans for 97 patients with bicuspid valve disease and compared them with 88 tricuspid aortic stenosis patients. Among these patients, 92% had type 1 bicuspid disease—the most common type seen among people of European descent. The devices used were those most commonly used in Europe (Sapien 3, Evolut R, and Lotus).

 

Measurements of the intercommissural distance were roughly similar between both patient groups, with intercommissural distance in bicuspid patients typically measured 4 mm above the level of the annulus. Annulus size was actually different between these groups, with a mean 23.6 mm for tricuspid patients and a mean 26.9 mm for bicuspid patients.


Read also: Multivessel Disease and Severe Carotid Stenosis: How to Proceed”.


The idea that bicuspid valves have a more elliptically shaped annulus was proven wrong in this work; the annulus shape is exactly the same, although the annulus for bicuspid patients is bigger.

 

Another assumption has been that transcatheter valves are typically implanted at a different height in bicuspid patients, but this was also proven wrong. Implantation depth was 3.4 mm in both patient groups.

 

Device sizing must be determined by the annular dimensions in tricuspid valves and by the intercommissural distance in bicuspid valves.

 

The study can conclude that the second-generation devices used work well in bicuspid patients (at least for type 1 bicuspid disease, which made up most of the cases in this study) and a dedicated device for this patient subgroup seems to be unnecessary.

 

Original title: Bicuspid Aortic Valve Anatomy and Relationship with Devices. The BAVARD Multicenter Registry.

Reference: Tchétché D et al. Presented at: PCR London Valves 2017. September 25, 2017. London, England.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...